- Home
- LIF vs KNSA Comparison
LIF vs KNSA Comparison
Compare LIF & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LIF | KNSA |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United Kingdom |
| Employees | 547 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | LIF | KNSA |
|---|---|---|
| Price | $46.37 | $56.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $75.58 | $60.86 |
| AVG Volume (30 Days) | ★ 832.9K | 820.0K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 225.00 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $677,564,000.00 |
| Revenue This Year | $36.21 | $37.48 |
| Revenue Next Year | $20.80 | $17.87 |
| P/E Ratio | $425.29 | ★ $202.22 |
| Revenue Growth | N/A | ★ 60.09 |
| 52 Week Low | $37.01 | $25.71 |
| 52 Week High | $112.54 | $55.00 |
Technical Indicators
Market Signals| Indicator | LIF | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 74.22 |
| Support Level | $37.41 | $40.67 |
| Resistance Level | $47.43 | N/A |
| Average True Range (ATR) | 2.12 | 2.32 |
| MACD | 0.21 | 1.32 |
| Stochastic Oscillator | 58.78 | 95.15 |
Price Performance
Historical ComparisonAbout LIF Life360 Inc.
Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.